ENTITY

Bicara Therapeutics (BCAX US)

5
Analysis
Health Care • United States
Bicara Therapeutics Inc. operates as a biotech company. The Company focuses on treating cancer head-on by combining the precision of targeted therapies with the power of tumor microenvironment modulators to create better medicines for patients. Bicara Therapeutics serves Worldwide.
more
Exchange Announcement • 26 Aug 2026 04:58

Current Report (Form 8-K | Period ending 2026-08-21)

Exchange Announcement • 12 Aug 2026 04:53

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 12 Aug 2026 04:46

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 11 Aug 2026 19:36

Current Report (Form 8-K | Period ending 2026-08-11)

Exchange Announcement • 28 Jul 2026 20:35

Current Report (Form 8-K | Period ending 2026-07-23)

x